Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (6)
  • 2025 (54)
  • 2024 (40)
  • 2023 (77)
  • 2022 (85)
  • 2021 (73)
  • 2020 (15)
  • 2019 (20)
  • 2018 (5)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4124)
  • Synthetic drugs (1103)
  • Guns/Weapons (1015)
  • OCDETF/Task Force (817)
  • Fake Pills (672)
  • Arrests/Convictions - Major (630)
  • Guilty Plea (541)
  • Seizures (Drugs/Property) (473)
  • Overdose (325)
  • Major Law Enforcement Operation (275)
  • Diversion Division (253)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (235)
  • Pharmaceuticals/Pharmacists/Physicians (227)
  • Money Laundering (210)
  • Gangs (200)
  • Outreach/Drug Prevention (187)
  • Fentanyl Awareness (160)
  • One Pill Can Kill (115)
  • HIDTA (104)
  • Press Conferences (68)
  • Narcoterrorism (54)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (51)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Counterfeit Pills (30)
  • Asset Forfeiture (29)
  • Dark Web- Internet Trafficking (29)
  • International/Foreign Operations (28)
  • Fentanyl Free America (27)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Campaigns (12)
  • Other (11)
  • Intergovernmental Affairs (9)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Prescription Drugs (371)
  • Critical Incident (7)

Drug Name

  • Oxycodone (77)
  • Fentanyl (57)
  • Opioids (57)
  • Hydromorphone (21)
  • Synthetic Opioids (21)
  • Methamphetamine (14)
  • Benzodiazepines (13)
  • Morphine (11)
  • Amphetamines (9)
  • Cocaine (9)
  • Heroin (6)
  • Methadone (5)
  • Marijuana (Cannabis) (4)
  • Steroids (3)
  • Ketamine (2)
  • GHB (1)
  • Marijuana Concentrates (1)
  • Psilocybin (1)

Field Division

  • Washington, DC (45)
  • St. Louis (39)
  • New York (35)
  • Sede (26)
  • Seattle (25)
  • New England (24)
  • Atlanta (20)
  • Miami (19)
  • Chicago (16)
  • Dallas (15)
  • New Jersey (15)
  • El Paso (14)
  • San Francisco (13)
  • Houston (12)
  • Louisville (10)
  • Los Angeles (9)
  • Omaha (9)
  • New Orleans (8)
  • Phoenix (8)
  • Rocky Mountain (6)
  • San Diego (6)
  • Detroit (3)
  • Philadelphia (1)
Clear All Results
378 Results - Showing 281 to 290
PRESS RELEASE

Man Indicted for Taking Controlled Substances from Kansas Hospital

KANSAS CITY, Kan. – A federal grand jury in Kansas returned an indictment charging an Overland Park, Kansas, man on two counts of tampering with a consumer product, one count of possession of fentanyl by deception and subterfuge, and one count of possession of hydromorphone by deception and subterfuge. According...
PRESS RELEASE

Federal Court Orders Tampa Pharmacy to Close in Case Alleging Unlawful Opioid Distribution

MIAMI - A federal court in Florida ordered a Tampa-area pharmacy shut down and prohibited two of its employees from ever owning, managing or operating any business where controlled substances are dispensed. Pursuant to an agreed consent judgment and permanent injunction filed in U.S. District Court for the Middle District...
PRESS RELEASE

DEA Holds National Prescription Drug Take Back Day to Turn the Tide Against the U.S. Opioid Epidemic

DALLAS– The Drug Enforcement Administration will host its 21st National Prescription Drug Take Back Day on Saturday, October 23 from 10 a.m. to 2 p.m. This event offers free and anonymous disposal of unneeded medications at more than 4,000 local drop-off locations nationwide. According to a report published by the...
PRESS RELEASE

DEA Holds National Prescription Drug Take Back Day to Turn the Tide Against the U.S. Opioid Epidemic

NEW ORLEANS – The Drug Enforcement Administration will host its 21st National Prescription Drug Take Back Day on Saturday, October 23 from 10 a.m. to 2 p.m. This event offers free and anonymous disposal of unneeded medications at more than 4,000 local drop-off locations nationwide. According to a report published...
PRESS RELEASE

DEA Holds National Prescription Drug Take Back Day to Turn the Tide Against the U.S. Opioid Epidemic

OMAHA, Neb. – The Drug Enforcement Administration will host its 21st National Prescription Drug Take Back Day on Saturday, October 23, from 10 a.m. to 2 p.m. This event offers free and anonymous disposal of unneeded medications at more than 4,000 local drop-off locations nationwide. According to a report published...
PRESS RELEASE

DEA Holds National Prescription Drug Take Back Day to Turn the Tide Against the U.S. Opioid Epidemic

SAN DIEGO - The Drug Enforcement Administration will host its 21st National Prescription Drug Take Back Day on Saturday, October 23 from 10 a.m. to 2 p.m. This event offers free and anonymous disposal of unneeded medications at more than 4,000 local drop-off locations nationwide. According to a report published...
PRESS RELEASE

Texas Physician Found Guilty for Unlawfully Prescribing Over 1.3 Million Doses of Opioids

HOUSTON - A federal jury convicted a Houston-area physician for unlawfully prescribing more than 1.3 million doses of opioids. According to court documents and evidence presented at trial, Parvez Qureshi, 56, of Houston, Texas, a medical doctor, conspired to and did unlawfully prescribe controlled substances from 2014 through February 2016...
PRESS RELEASE

Funeral Arrangements for DEA Supervisory Special Agent Michael G. Garbo

PHOENIX, Ariz. – A public funeral for Drug Enforcement Administration Supervisory Special Agent Michael G. Garbo will be held on Friday, October 8, 2021, at Calvary Chapel in Tucson. Special Agent Garbo died Monday as a result of injuries sustained during a shooting in downtown Tucson. Friday’s service will honor...
PRESS RELEASE

DEA Administrator Anne Milgram Releases Statement on Tucson Shooting

Washington - Yesterday, two DEA Special Agents and a DEA Task Force Officer from the Tucson Police Department were involved in a shooting incident during a law enforcement operation in Tucson, Arizona. The DEA is deeply saddened to report that DEA Group Supervisor Michael G. Garbo died as a result...
PRESS RELEASE

Creve Coeur Pharmacy and Owner to Pay $1.4 Million for Ignoring Signs of Illegal Drug Prescriptions

ST. LOUIS – Olive Street Pharmacy, LLC, and pharmacy technician Irina Shlafshteyn, agreed to pay $1,507,808.50 to resolve a civil complaint bringing claims under the False Claims Act and Controlled Substances Act related to the unlawful dispensing of controlled substances, including some that were submitted to Medicaid or Medicare for...

Paginación

  • Primera página «
  • Anterior
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Current page 29
  • Page 30
  • Page 31
  • Page 32
  • Page 33
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster